Synopsys (SNPS) › Analysis

Synopsys (SNPS) stock analysis, November 3, 2026: Outpacing a tech selloff, weekly uptrend intact

Published November 3, 2026 · SNPS chart, levels and live analysis

Synopsys (SNPS) is down 2.7% over five days, a small loss next to the 7.1% drop in the technology sector fund XLK, and the stock still trades above its 40-week average. The balance of evidence leans positive for the next two to six weeks, with high conviction (3 of 4 points). The pullback from the October 9, 2026 peak is real, though, and a weekly close below $444.76 would change the picture.

Why it matters

No single event drove SNPS lower this week. Today the shares gave back 0.9% while the S&P 500 rose 0.2% and XLK gained 1.1%, and nothing in the news explains that gap. The company-specific news has been constructive. Investing.com reported on October 26, 2026 that S&P raised the credit rating to BBB+ and now projects mid-teens annual revenue growth through 2029, up from roughly 10%. Yahoo Finance noted fiscal 2026 revenue guidance of $9.69 billion to $9.74 billion. Even so, the stock is down 5.7% over a month and 9.4% below its October 9 close of $509.99, so good news did not stop the slide. The cause looks like the sector, not the company. Bloomberg tied an October week of stock losses to worries about AI-related investment, in a piece featuring the finance chiefs of Arm and Synopsys.

Over five days SNPS fell 2.65%, the S&P 500 fell 2.06% and XLK fell 7.07%. Most of the stock's loss therefore matches the broad market, and the sector fell far harder. SNPS beat XLK by 4.4 points in that window. Over a month the stock is down 5.7% against 11.9% for XLK. The stock's own contribution has been resilience, not weakness. The CEO's October 15 sale does not change this. Investing.com reported that Ghazi Sassine sold 14,604 shares for $6.76 million at about $462.84, after exercising options struck at $135.88, under a pre-arranged Rule 10b5-1 plan. That price is almost exactly where the stock trades today. Separately, Bloomberg covered Marvell's $102.6 billion acquisition. It shows chip-sector deal activity but has no stated link to SNPS shares.

The published debate leans one way. Yahoo Finance set Synopsys against IBM, citing fiscal 2025 revenue of $7.1 billion, up 15.1%, and an 18.9% net margin. It also flagged stock-based compensation as a cost. The Motley Fool argued Synopsys is the stronger of it and Salesforce. None of the articles gathered makes an outright negative case. The cautious argument shows up in the tape instead: investors are questioning how much AI-linked spending the whole technology sector can justify, and chip-design software sits downstream of that spending. The real question is whether mid-teens growth survives that scrutiny.

Valuation does not argue against the stock. Twenty-five analysts rate it a strong buy, with a mean price target of $586.95, a low of $475 and a high of $700. The shares are 21.3% below the mean target, and even the lowest target sits above today's $461.83. The market cap is about $88.5 billion.

What the evidence says

The long-term thesis is intact. Price is above both its 10-week and 40-week averages, and the 50-day average ($440.19) and 200-day average ($442.99) sit just below the current price. The stock is in a pullback inside an uptrend, 13.6% under its 52-week high of $534.56 but 25.6% above its low of $367.7. The year-to-date picture is less flattering: SNPS is down 1.7% against 10.5% for the S&P 500 and 22.3% for XLK. Over 50 days, though, it leads the S&P 500 by 6.8% and XLK by 12.9%.

For the next two to six weeks the balance of evidence leans positive, with high conviction at 3 of 4 points. The daily trend runs with the weekly uptrend, and the stock is leading both the market and its sector over 50 days. That combination matters because the stock has fallen less than the group it belongs to, which is how a leader behaves in a pullback. The fourth point is not met, and the soft spots in the data are the ones below.

The strongest case against this reading is momentum and participation. The RSI is 44.4, volume is running 56.2% below its 20-day average (the session is still in progress), and the stock has lost 5.7% in a month. Thin volume can mean sellers have stepped back, but it can also mean buyers have not arrived. This is why conviction stops at 3 of 4. It does not tip the balance, because the stock is still above its 50-day and 200-day averages and its relative strength has held through a sector decline of 11.9%.

Levels that matter

The structure rests above $453.52, a swing zone, with the round $450 just beneath it. A slip under $453.52 would be the first crack. The trend ends below $444.76, another swing zone, which sits just above the 50-day average at $440.19 and the 200-day at $442.99. A break there would take price into the cluster of averages that has supported the advance.

The breakout level is a daily close above $467.03 on volume above its 20-day average. From there the first target is $481.01, which gives only 0.8 to 1 against a stop at $448.58 (the $453.52 zone minus a quarter of the 14-day ATR of $19.75). The second target is the 52-week high at $534.56, which gives 3.7 to 1. The math therefore reaches 3 to 1 only if the move runs the full distance to the high. The round numbers $475 and $500 lie on the way and could slow it.

What would change the picture

A weekly close below $444.76 would change the picture, because it would break the swing zone that marks the end of the trend. The non-price fact most likely to do it is a cut to fiscal 2026 revenue guidance of $9.69 billion to $9.74 billion, or signs that AI-driven chip-design demand is slowing. That would undercut the mid-teens growth that S&P and the analysts are assuming.

What to watch

Get a message when the SNPS picture changes — the agent team watches the levels and the news for you.Create a free account

More SNPS analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.